Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Clayton R, Rowland"'
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 10:59-66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3845779e01046b4e749216ad85d640
https://doi.org/10.1111/j.1365-2710.1985.tb00716.x
https://doi.org/10.1111/j.1365-2710.1985.tb00716.x
Autor:
Anita Krishnamurthy, Meryl Brod, Clayton R. Rowland, Kathleen J. Jirgens, Shoshana S. Colman, Baltazar Gomez-Mancilla
Publikováno v:
Clinical Therapeutics. 23:127-145
Background: Patient-reported outcomes, such as treatment satisfaction, functional status, and health-related quality of life (HRQOL) are essential components of migraine research. Almotriptan is a new selective serotonin 1B/1D agonist triptan migrain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00e13618d35da394313f4fbf1dfaf543
https://doi.org/10.1016/s0149-2918(01)80036-9
https://doi.org/10.1016/s0149-2918(01)80036-9
Autor:
Mohan V. Bala, Robert G. Holloway, Clayton R. Rowland, Marianne Greer, Elizabeth A. Chrischilles, Thomas J. Hoerger
Publikováno v:
PharmacoEconomics. 14:541-557
Pramipexole was recently approved in the US for treatment of the symptoms of idiopathic Parkinson's disease (PD). Although pramipexole has been found to be safe and efficacious when compared with placebo, little data are yet available on its cost eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932c73056176e14111781a55c00cce06
https://doi.org/10.2165/00019053-199814050-00006
https://doi.org/10.2165/00019053-199814050-00006
Autor:
Clayton R Rowland, James Broatch, Eric Hollander, Dan J. Stein, Cheryl M. Wong, Carol Himelein, Jee H. Kwon
Publikováno v:
CNS Spectrums. 2:16-25
The study presented was conducted to analyze the effects of obsessive-compulsive symptoms on patients' quality of life and the costs incurred by patients and society for the treatment of obsessive-compulsive disorder (OCD). To accomplish this, a deta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6551698034c917520e678076b000cfd
https://doi.org/10.1017/s1092852900011068
https://doi.org/10.1017/s1092852900011068
Autor:
Sarah S. Shiraki, Henrick J. Harwood, Dorothy P. Rice, Robert L. DuPont, Clayton R. Rowland, Leonard S. Miller
Publikováno v:
Anxiety. 2:167-172
Anxiety disorders are estimated to affect 26.9 million individuals in the United States at some point during their lives. This study used the human capital approach to estimate the direct and indirect costs of these highly prevalent disorders. In 199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::435269505f10af8fa7fc901e38e408c0
https://doi.org/10.1002/(sici)1522-7154(1996)2:4<167::aid-anxi2>3.0.co
https://doi.org/10.1002/(sici)1522-7154(1996)2:4<167::aid-anxi2>3.0.co
Publikováno v:
The journal of mental health policy and economics. 8(3)
Depression is a common disorder that impacts an individual's ability to perform life activities, including those required by the workplace. Academic performance can be viewed as a direct parallel to workforce performance, with students belonging to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc14366d583b166e3cbd9452271e8ec5
https://pubmed.ncbi.nlm.nih.gov/16278502
https://pubmed.ncbi.nlm.nih.gov/16278502
Autor:
Warren H. Schonfeld, Elizabeth A. Rothermich, Baltazar Gomez-Mancilla, Meryl Brod, Clayton R. Rowland
Publikováno v:
PharmacoEconomics. 20(11)
Patient-reported outcomes (PROs), including resource utilisation, productivity and quality of life, are important outcomes in the field of migraine. Clinical trials have begun to incorporate PROs; however, not all research questions can be answered f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4275c570a62f356e74f348c13f2a846f
https://pubmed.ncbi.nlm.nih.gov/12201791
https://pubmed.ncbi.nlm.nih.gov/12201791
Autor:
Scott Bull, Joseph R Schwab, Stephen W. Hurt, Janelle Y. Lee, Todd E Williamson, Enid M. Hunkeler, Clayton R. Rowland
Publikováno v:
The Annals of pharmacotherapy. 36(4)
OBJECTIVE: To describe reasons for discontinuing or switching selective serotonin-reuptake inhibitors (SSRIs) at 3 and 6 months after starting treatment, and to identify information provided to patients that may help prevent premature discontinuation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d16e6164f4be5198dd10cd209d25fa2
https://pubmed.ncbi.nlm.nih.gov/11918502
https://pubmed.ncbi.nlm.nih.gov/11918502
Autor:
Joseph T, Wang, Charles E, Barr, Yas, Torigoe, Elaine, Wang, Clayton R, Rowland, Scott D, Goldfarb
Publikováno v:
The American journal of managed care. 8
This article constructs an economic model to estimate cost of chest-pain-related care in migraine patients receiving almotriptan 12.5 mg compared with those receiving sumatriptan 50 mg.This population-based, retrospective cohort study used data from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ffd479ed5ea2c2a4c5b44ccc19822a80
https://pubmed.ncbi.nlm.nih.gov/12212757
https://pubmed.ncbi.nlm.nih.gov/12212757
Autor:
Ruth Q. Calucin, Sheila Fifer, Clayton R. Rowland, Edward H. Yelin, Susan D. Mathias, Don P. Buesching
Publikováno v:
Social sciencemedicine (1982). 42(7)
Anxiety is a common, though often unrecognized, problem in primary care settings. This study examines the effect on employment of an intervention designed to attune primary care physicians to previously unrecognized and untreated anxiety. Primary car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1277d8db7855cee9dad398df3dec7217
https://pubmed.ncbi.nlm.nih.gov/8730912
https://pubmed.ncbi.nlm.nih.gov/8730912